BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In summary, these data suggested that integrin β3 plays a role in the outcome of, particularly, BCR-ABL1T315I+ CML, while also influencing the differentiation of BCR-ABL1+ and BCR-ABL1T315I+ myeloid cells.